A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Anaplastic Lymphoma Kinase · Anaplastic Large Cell Lymphoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Memorial Sloan Kettering Basking Ridge (LimitedProtocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Robert Stuver, MD) · 646-608-4308
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Robert Stuver, MD) · 646-608-4308
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Robert Stuver, MD) · 646-608-4308
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Robert Stuver, MD) · 646-608-4308
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Robert Stuver, MD) · 646-608-4308
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Robert Stuver, MD) · 646-608-4308
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Robert Stuver, MD) · 646-608-4308
מובילי המחקר
  • Robert Stuver, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center